Vahhab Piranfar
Microbiologist Β· Antimicrobial Resistance Researcher Β· Computational Modeler
antimicrobial resistance, bacterial modeling, antibiotic PK/PD, antimicrobial pharmacometrics, Monte Carlo simulation, virtual populations, clinical microbiology, reproducible research

Molecular Microbiologist Β· EB-1A Recipient
Modeling bacterial pathogens, antibiotic exposure, and antimicrobial resistance
I work at the intersection of clinical microbiology, antimicrobial resistance, and computational modeling. My research combines bacterial evidence, antibiotic PK/PD, virtual populations, and reproducible simulation to investigate pathogen behavior, treatment response, and resistance.
π¦ Antimicrobial Resistance π Bacterial Modeling π Antibiotic PK/PD π¬ Clinical Microbiology
Explore my projects Read my publications
33+ Publications
650+ Citations
15+ Yrs Experience
EB-1A Recognition
The science, visualized
From bacterial evidence to antibiotic target attainment
My work turns fragmented pharmacokinetic/pharmacodynamic evidence into simulations of how antibiotic exposure clears bacterial pathogens. The curve traces drug concentration over time; the shaded band is the window where exposure stays above the MIC and the bacterial population is suppressed.
Antibiotic concentration MIC threshold Time above MIC (target attainment) Bacterial population
Clinical Microbiology
Pathogen detection, molecular diagnostics, antimicrobial susceptibility, and resistance research across clinical and translational settings.
Antibiotic & Bacterial Modeling
PK/PD simulation, virtual populations, bacterial-response modeling, and quantitative analysis of antibiotic exposure and target attainment.
Reproducible Research Systems
Provenance-aware evidence synthesis, scientific software, simulation workflows, and transparent computational research packages.
Current focus
I am a molecular microbiologist and computational researcher working on antimicrobial resistance, bacterial pathogens, and antibiotic PK/PD modeling. Based in Jersey City, New Jersey, I combine clinical laboratory experience with pharmacometric simulation, bioinformatics, molecular modeling, and provenance-aware evidence synthesis. My current research focuses on converting fragmented antimicrobial evidence into reproducible models of antibiotic exposure, bacterial response, target attainment, and resistance-related uncertainty.
Vision Statement
βThe microscope remains essential, but it is no longer our only lens. By combining microbiology with computational modeling, we can study how bacterial pathogens, antibiotic exposure, and resistance interact across scales.β
β Vahhab Piranfar